Avasarala, Jagannadha <br/><br/>
Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.  [electronic resource] 

 -  Neurology  09 2018 
 - 580 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1526-632X 
<br/><br/><label>Standard No.: </label>10.1212/01.wnl.0000544324.09014.0e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Antibodies, Monoclonal, Humanized<br/>Humans<br/>Multiple Sclerosis, Relapsing-Remitting